Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series. Pharm Pract (Granada) [Internet]. 2019 Dec. 12 [cited 2025 Oct. 22];17(4):1588. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/1588